COMP <GO>
UPC vs LEXX // OPERATING MARGIN
Universe Pharmaceuticals Inc. (Class A) (NASDAQ) VS. Lexaria Bioscience Corp. (NASDAQ) • 15-METRIC TALLY: UPC 3
— LEXX 4
▲ OPERATING MARGIN LEADER: UPC
LAST: $1.49 (-3.25%) • MKT CAP: $7.5M
operating-margins
-16.30%
LAST: $3.49 (-7.43%) • MKT CAP: $7.4M
operating-margins
-60.00%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (UPC VS. LEXX)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | UPC | LEXX | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 35.30% | 96.00% | -60.70 | LEXX | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | — | -35.00% | — | TIE | /roic <GO> |
| EV/EBITDA & P/E Valuation | — | — | — | TIE | /valuation <GO> |
| Free Cash Flow Yield | — | — | — | TIE | /fcf-yield <GO> |
| Operating Margin ACTIVE | -16.30% | -60.00% | +43.70 | UPC | /operating-margins <GO> |
| Net Profit Margin | -20.60% | -60.00% | +39.40 | UPC | /net-margins <GO> |
| Revenue Growth (YoY) | -22.40% | 52.00% | -74.40 | LEXX | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | — | — | — | TIE | /balance-sheet <GO> |
| Piotroski F-Score Quality | 2/9 | 4/9 | -2.00 | LEXX | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 22.9 | 48.6 | -25.70 | LEXX | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | — | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | — | — | — | TIE | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $7.5M | $7.4M | $134.6K | UPC | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | UPC REV | LEXX REV | UPC GROSS % | LEXX GROSS % | UPC FCF | LEXX FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $17.86B | $705.9K | 35.3% | 98.0% | -$5.32B | -$10.5M |
| FY 2024 | $23.02B | $464.3K | 26.4% | 98.0% | -$9.72B | -$5.0M |
| FY 2023 | $32.31B | $226.2K | — | — | $1.12B | -$5.9M |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
UPC // BETA —
LEXX // BETA —